Can IL-23 Inhibitors Change the Conversation About Psoriasis Remission?

(MedPage Today) -- Psoriasis treatment strategies were a key focus of discussion at the American Academy of Dermatology (AAD) annual meeting. MedPage Today spoke with E. James Song, MD, of Frontier Dermatology in Washington, about whether interleukin...
Source
MedPage Today
Opens original article in a new tab



